Chimeric marker vaccine candidates, vGPE/PAPeV E and vGPE/PhoPeV E, have been generated and their efficacy and capability to differentiate infected from vaccinated animals were confirmed in previous studies. The safety profile of the two chimeric marker vaccine candidates, particularly in the potential reversion to virulence, was evaluated. Each virus was administered to pigs with a dose equivalent to the vaccination dose, and pooled tonsil homogenates were subsequently inoculated into further pigs.
View Article and Find Full Text PDFcan cause infection in ruminants, and its pathogenicity is suggested to be associated with VapN. Despite its wide distribution, no immunological diagnostic method has been developed for VapN-producing . Against this background, we attempted to develop monoclonal antibodies targeting VapN and assess their application in immunostaining.
View Article and Find Full Text PDF